Atlas Trials

High Dose Intravenous Thiamine for the Prevention of Delirium in Allogeneic Hematopoietic Stem Cell Transplantation

Clinical trial NCT03263442 · COMPLETED

Trial details

NCT number
NCT03263442
Sponsor
UNC Lineberger Comprehensive Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hematopoietic Stem Cell TransplantationDeliriumThiamine Deficiency
Start date
2017-10-16
Primary completion
2020-03-02
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.